107 related articles for article (PubMed ID: 11230752)
21. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection.
Mangia A; Santoro R; Piattelli M; Pazienza V; Grifa G; Iacobellis A; Andriulli A
Cytokine; 2004 Feb; 25(3):103-9. PubMed ID: 14698136
[TBL] [Abstract][Full Text] [Related]
22. [Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].
Pár A
Orv Hetil; 2011 May; 152(22):876-81. PubMed ID: 21565755
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
24. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy.
Malhotra D; Darvishi K; Sood S; Sharma S; Grover C; Relhan V; Reddy BS; Bamezai RN
Hum Genet; 2005 Nov; 118(2):295-300. PubMed ID: 16163478
[TBL] [Abstract][Full Text] [Related]
25. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
Hijikata M; Ohta Y; Mishiro S
Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
[TBL] [Abstract][Full Text] [Related]
26. Association of haplotypes of interleukin-10 gene with the risk of cancer.
Pogoda TV; Marsheva OV; Kostin PA; Maksimov VN; Kulikov IV; Openko TG; Simonova GI; Voyevoda MI; Generozov EV; Govorun VM
Bull Exp Biol Med; 2007 Sep; 144(3):385-9. PubMed ID: 18457043
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy.
Constantini PK; Wawrzynowicz-Syczewska M; Clare M; Boron-Kaczmarska A; McFarlane IG; Cramp ME; Donaldson PT
Liver; 2002 Oct; 22(5):404-12. PubMed ID: 12390476
[TBL] [Abstract][Full Text] [Related]
28. Common Polymorphisms of
Rezaei F; Doulatparast D; Sadeghi M
J Interferon Cytokine Res; 2020 Jul; 40(7):357-369. PubMed ID: 32598201
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.
Knapp S; Hennig BJ; Frodsham AJ; Zhang L; Hellier S; Wright M; Goldin R; Hill AV; Thomas HC; Thursz MR
Immunogenetics; 2003 Sep; 55(6):362-9. PubMed ID: 12942209
[TBL] [Abstract][Full Text] [Related]
30. ASSOCIATION OF INTERLEUKIN-10 -592A>C AND -819T>C POLYMORPHISMS WITH GASTRIC CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 44 CASE-CONTROL STUDIES.
Moghmi M; Arjmandi A; Aghili K; Jafari M; Zare-Shehneh M; Rastegar S; Abolbaghaei SM; Neamatzadeh H
Arq Bras Cir Dig; 2019 Jan; 32(1):e1415. PubMed ID: 30624524
[TBL] [Abstract][Full Text] [Related]
31. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
Neuman MG; Benhamou JP; Martinot M; Boyer N; Shear NH; Malkiewicz I; Katz GG; Suneja A; Singh S; Marcellin P
Clin Biochem; 1999 Oct; 32(7):537-45. PubMed ID: 10614716
[TBL] [Abstract][Full Text] [Related]
32. Involvement of IL-10 gene promoter polymorphisms in the susceptibility for childhood asthma.
Kim KW; Lee KE; Hong JY; Kim MN; Heo WI; Sohn MH; Kim KE
Lung; 2011 Oct; 189(5):417-23. PubMed ID: 21779975
[TBL] [Abstract][Full Text] [Related]
33. The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-alpha and ribavirin combined therapy for chronic hepatitis C patients.
Chen PJ; Hwang Y; Lin CG; Wu YJ; Wu LS
Int J Immunogenet; 2008 Apr; 35(2):153-7. PubMed ID: 18279371
[TBL] [Abstract][Full Text] [Related]
34. ACC interleukin-10 gene promoter haplotype as a breast cancer risk factor predictor among Jordanian females.
Atoum MF
Onco Targets Ther; 2016; 9():3353-7. PubMed ID: 27330315
[TBL] [Abstract][Full Text] [Related]
35. TNFA -308G>A and IL10 -1082A>G polymorphisms seem to be predictive biomarkers of chronic HCV infection.
Santiago AM; da Silva Graça Amoras E; Queiroz MAF; da Silva Conde SRS; Cayres-Vallinoto IMV; Ishak R; Vallinoto ACR
BMC Infect Dis; 2021 Nov; 21(1):1133. PubMed ID: 34732154
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection.
Ren S; Yu H; Zhang H; Liu Y; Huang Y; Ma L; Wei L; Wu H; Chen X
Antiviral Res; 2011 Mar; 89(3):232-7. PubMed ID: 21277331
[TBL] [Abstract][Full Text] [Related]
37. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina.
Hassan MI; Aschner Y; Manning CH; Xu J; Aschner JL
Cytokine; 2003 Jan; 21(1):10-6. PubMed ID: 12668154
[TBL] [Abstract][Full Text] [Related]
38. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection.
Lio D; Caruso C; Di Stefano R; Colonna Romano G; Ferraro D; Scola L; Crivello A; Licata A; Valenza LM; Candore G; Craxì A; Almasio PL
Hum Immunol; 2003 Jul; 64(7):674-80. PubMed ID: 12826369
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C.
Cussigh A; Falleti E; Fabris C; Bitetto D; Cmet S; Fontanini E; Bignulin S; Fornasiere E; Fumolo E; Minisini R; Pirisi M; Toniutto P
Immunogenetics; 2011 Jan; 63(1):33-41. PubMed ID: 21072509
[TBL] [Abstract][Full Text] [Related]
40. Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection.
Yee LJ; Knapp S; Burgner D; Hennig BJ; Frodsham AJ; Wright M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2004 May; 5(3):183-7. PubMed ID: 14985675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
